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Background. The eﬀective hemostasis after minor debridement in an outpatient clinic is important and essential. This study is
aimed at evaluating the hemostatic eﬃcacy and safety of the kaolin-impregnated dressing for diabetic foot ulcer patient who
take an anticoagulant. Methods. A prospective, randomized, clinical trial study was performed in twenty-six patients with
diabetic foot ulcers who take an anticoagulant requiring minor debridement in an outpatient clinic. Minor debridement and
removal of break down skin were performed by one orthopedic surgeon. Hemostasis on wound bed was achieved using kaolin-
impregnated gauze (study group) and standard sterilized dry gauze (control group). Two randomized groups were compared for
hemostatic eﬃcacy and side eﬀect. Results. For the purpose of this study, the presence or absence of hemostasis was assessed at 5
and 10 minutes after the application of dressing material. Treatment was evaluated as successful if bleeding was ceased
adequately, and no extra hemostatic measures were required within 10 minutes. At 5 minutes, 80% of patients using the kaolin-
impregnated gauze successfully achieved complete hemostasis versus 40% in the control group that controlled bleeding partially.
With kaolin-impregnated gauze, 100% of patients show complete hemostasis at 10 minutes versus 58.3% in the standard gauze
(P < :001). An adverse eﬀect was not noted in all patients. Conclusions. The use of kaolin-impregnated gauze appears to be a safe
and feasible option in managing bleeding after debridement of diabetic foot ulcers, and merits to patient who had a bleeding
tendency is high. This trial is registered with CRIS registration number KCT0003894.
1. Introduction
Repeated minor debridement for superﬁcial or deep diabetic
foot ulcer with infection is an essential procedure to remove
necrotic tissue including the bone, abscess, and provides a
low rate of local complications [1]. Removal of the infected
bone or break downed skin during minor debridement based
on an outpatient clinic is conventionally followed on external
compression achieved with a simple sterilized gauze applied
to the debrided ulcer site [2]. Besides, the vasculopathy is a
common complication of diabetic patient, who have to
receive anticoagulation therapy for protecting cardiovascular
attack and atherosclerotic change of vessels. In diabetes
patient, a propensity for platelet activation and aggregation,
coupled with a tendency for coagulation, is relevant to a risk
of thrombosis complicating plaque rupture [3]. With those
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conditions, hemostasis after debridement is relatively impor-
tant but usually considered as a suspended complication of
aggressive procedures because of the small amount of
bleeding. However, the bleeding tendency of diabetic ulcer
increases due to anticoagulation therapy. Hence, there is a
growing interest to reduce hospital stay after interventional
procedures and to ﬁnd alternative bleeding control methods
to avoid collagen-based or suture-based hemostasis in patient
settings, without increasing procedural complications.
Currently, there are many studies that reported eﬀective-
ness after kaolin-impregnated dressing in trauma [4, 5] and
percutaneous vascular intervention [6, 7], but the advantages
in terms of eﬃcacy of these materials compared to conven-
tional sterilized gauze have never been demonstrated for
hemostasis in diabetic foot ulcer undergoing surgical
debridement based on an outpatient clinic.
The purposes of this study were to examine the
eﬀectiveness and safety to evaluate the hemostatic eﬀect
of kaolin-impregnated gauze on diabetic foot ulcer patients
who continuously take anticoagulants, comparing with a
control group on hemorrhage control after debridement
in a diabetic foot ulcer [8].
2. Patients and Methods
All consecutive patients undergoing major or minor debride-
ment or superﬁcial necrotic tissue removal procedures between
March 31, 2016 and June 22, 2016 at an outpatient clinic of a
university hospital were considered to be enrolled in the study.
After that, the patients were randomized in a 1 : 1 fashion to
conventional manual compression methods with sterile dry
gauze or kaolin-impregnated gauze for achieving hemostasis.
Randomization was based on a computer-generated randomi-
zation list. All patients were enrolled to the study with the
following inclusion criteria: (1) patients over 20 years old
who have type I or II diabetes mellitus (DM), (2) an ulcer
was Wagner grade I or II ulcer, (3) above 2 cm diameter size
which lasted more than six weeks without infection or inﬂam-
mation (local tenderness, erythema, generalized fever, and leu-
kocytosis), (4) good extremity circulation status, palpable
pulse, or conﬁrmation with Doppler sonography at the ankle
(dorsalis pedis artery or posterior tibial artery), (5) received
anticoagulation therapy due to diabetic vasculopathy or sys-
temic disease, and (6) patients who agreed the written consent
form after full description of the clinical trial. Patients that were
excluded from the study were pregnant patients, patients
undergoing immunosuppressant therapy, and patients with
systemic cardiopulmonary disease. Also, patients who does
not understand or agree to this study were excluded.
2.1. Sample Size Calculation. A previous similar study
showed that received chitosan dressings reduced survival
time compared with gauze sponges [9]. The average success
rate of hemostasis after 5 minutes was acquired 0.1% (gauze
sponges) and 62% (chitosan-based hemostatic dressing),
respectively. Similarly, the sample size estimate for the
present study was 13 patients in each group based on the
following calculation. Assuming α = 0:05 and 1‐β = 0:9 and
that the ratio of the two groups is 0.001 and 0.620, it was
calculated as 10 patients for each group. We chose to include
26 patients (13 in each group) to adjust for an estimated 20%
dropout rate [10] (PASS version 15, NCSS, LLC, Kaysville,
Utah, USA).
2.2. Study Design. A total of 26 patients enrolled to ﬁnd out a
statistically signiﬁcant diﬀerence in the complete bleeding
control between the two groups. At ﬁrst visit, qualiﬁed
patient was distinguished based on physical examination
along with foot radiography and routine laboratory test
(complete blood count, routine chemistry screen, urinary
analysis, and vital sign checkup), and previous medical
records were reviewed. Those patients were randomized into
the two diﬀerent groups with a 1 : 1 ratio. After achieving the
fresh bleeding on the wound bed and based on a computer-
generated randomization list, the patients were allocated into
one of the following strategy groups. Study group: the
compression of wound bed was obtained with kaolin-
impregnated gauze applied directly after procedure. Control
group: hemostasis was obtained by direct compression of
wound bed with a folded conventional sterile gauze wrapped
with tape and maintained for 5 minutes while patients in the
control group were managed with conventional manual com-
pression dressing using dry gauze (sterilized gauze, DaeHan
Medical, Chungju, South Korea) after procedures. During
the treatment, the anticoagulation therapy is continued as
usual. Moreover, to observe, a side eﬀect, either reported by
the patients or inspected by the investigator, was checked
using a standardized protocol through the study.
2.3. Product Description. Kaolin-impregnated hemostatic
dressing is ﬂexible, nonwoven coated gauze (50-50 rayon/-
polyester, 2∗2 inch). Kaolin is an aluminum silicate, a very
potent coagulation initiator that acts as a surface activator
with a hemostatic eﬀect caused by the activation of the
intrinsic clotting pathway [11, 12]. The gauze is stable
after opening the external aluminum envelope. It is absor-
bent and has a good clotting ability. This advanced clotting
gauze is a Food and Drug Administration (FDA) and Korean
Food and Drug Administration (KFDA) cleared device.
2.4. Study Protocol. The basic dressing protocol was stan-
dardized as follows (Figure 1):
(1) Through cleansing of the wound bed and margin
with normal saline
(2) Additional debridement to remove necrotic tissues
and expose healthy bleeding margin if necessary
(3) Direct application of the dressing material to wound
bed then compress with constant pressure manually
for 5 minutes by a trained registered nurse who was
specialized in wound care
(4) At the time of estimated 5 minutes, the presence or
absence of hemostasis was assessed at that time
(5) Test treatment was repeated if hemostasis was not
achieved after 5 minutes. Hemostasis was assessed
again at 10 minutes after treatment starts
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2.5. Hemostatic Endpoint. The deﬁnition of hemostatic end-
point was the complete stopping status of bleeding on the
debrided wound bed, and no further compression was
required to control bleeding at the debridement site [6].
The treatment was rated as eﬀective if bleeding was stopped
suﬃciently, and no additional hemostatic measures were
necessary within 10 minutes. The bleeding tendency and
complication rate was evaluated and analyzed. Patients were
evaluated at 5 minutes and 10 minutes after hemostasis
achievement for complications.
2.6. Statistical Analysis. Patient characteristics and clinical
outcomes are presented asmean ± SD or count (percentage).
We ﬁrst performed the Shapiro-Wilk normality test to check
for normal distributions of study variables. If normality tests
were passed, an independent t test was used. If normality
tests were failed, the Mann-Whitney test was used for com-
parisons after treatment. Statistical analyses were performed
using SPSS software (Version 18.0, IL, Chicago, USA). A sig-
niﬁcance level of 5% was used for all analyses.
2.7. Ethical Considerations. Approval to conduct the study
was given by the Gangnam Severance Hospital, Institutional
Review Board (No. 3-2014-0083) in accordance with the
Declaration of Helsinki, and written informed consent was
obtained from all patients prior to the study.
3. Results
3.1. Demographics. Of the enrolled 26 patients (13 for each
group) in the study and followed for endpoints, two patients
were stopped because of a high rate of active bleeding after
debridement of all necrotic tissue and surrounding callus.
Subsequently, the randomization was done with 12 patients.
The demographics and medical history of the two groups
are presented in Table 1. Initial diabetic foot ulcer status also
compares with two assigned groups regarding the period of
morbidity of diabetic foot ulcer, ulcer size, and grade in
Table 2. No major adverse events such as uncontrolled major
bleeding, acute infection sign, and newly developed ulcers
were observed.
3.2. Safety and Eﬃcacy. Safety of the studied dressing
materials was evaluated by the percentage of patients
experiencing complications deﬁned as rebleeding or hema-
toma. An adverse event was deﬁned as acute local infection,
either clinical or in laboratory results with a minimum
follow-up of 8 weeks.
3.3. Clinical Result of Hemostatic Endpoint. The use of
kaolin-impregnated gauze resulted in a signiﬁcant improve-
ment of the time to complete hemostasis and overall
hemostatic success. Patients treated with the kaolin gauze
successfully achieved complete hemostasis at 5 minutes in
80% of cases, whereas only 40% of patients in the control
group had partially stopped bleeding (P = :001). At 10
minutes, 100% of patients of the study group had hemo-
static success versus 58.3% in the control group (P < :001).
Thus, hemostasis was achieved after a study protocol in all
of the study group and three patients in the control group.
In two remaining patients who did not acquire hemostasis,
we applied more compression time to the wound with ban-
dage. Analysis of bleeding tendency through coagulation
proﬁles of the two groups is presented in Table 3. Neither
(a) (b)
(c)
Figure 1: Serial hemostatic procedures of conventional manual compression dressing using a kaolin-impregnated dressing (study group) or
dry gauze (control group) for a diabetic foot ulcer after surgical debridement. (a) Devitalized margin of the diabetic foot ulcer was debrided
using a surgical blade. (b) Application of kaolin-impregnated dressing after soaking to the ulcerative wound using sterilized forceps. (c)
Manual compression with constant pressure.
3Journal of Diabetes Research
rebleeding nor hematoma occurred after the removal of
dressing materials. Patients were on aspirin (6/24, 26.3%),
clopidogrel (5/24, 20.8%), aspirin and clopidogrel (11/24,
45.8%), aspirin and LMHW (1/24, 4.2%), and warfarin
(1/24, 4.2%). The type of anticoagulants of each group of
patients is presented in Table 4.
3.4. Clinical Follow-Up. A telephone contact at 1 month was
done to two patients (one each group) who have experienced
a high rate of active bleeding after debridement. No major
events on wound occurred.
4. Discussion
This study demonstrated that kaolin-impregnated gauze is a
useful option to apply quick hemostasis for debrided diabetic
foot ulcer. For standardized treatment to diabetic foot ulcers,
currently many other therapeutic interventions existed: oﬀ-
loading, dressings, topical therapies, electrophysical therapy,
negative pressure wound therapy, platelet-rich plasma and
surgical debridement, and so on. Among them, debridement
is essentially considered a part of diabetic foot ulcer standard
care [13]. It arise removal of callus and abnormal margin
Table 1: Demographics and initial evaluations of patients.
Control
(n = 12, 50.0%)
Study
(n = 12, 50.0%) P value
Age (years) 58:9 ± 11:5 68:7 ± 10:8 .065
Gender (men : women) 7 : 5 6 : 6
Body mass index (kg/m2) 24:6 ± 2:7 24:1 ± 4:3 .773
Systolic BP (mmHg) 136:0 ± 18:3 134:0 ± 21:2 .823
Diastolic BP (mmHg) 70:9 ± 11:3 73:0 ± 8:2 .640
Heart rate (/min) 82:7 ± 12:1 77:1 ± 16:6 .400
White blood cells (×103/μl) 7:5 ± 3:7 6:5 ± 1:6 .089
HbA1c (%) 8:8 ± 2:9 7:9 ± 1:4 .426
Duration of diabetes (years) 15:9 ± 7:5 22:8 ± 12:4 .157
Smoking
Nonsmoker 23 (74.2%) 16 (51.6%)
Former smoker 5 (16.1%) 14 (45.2%)
Smoker 3 (9.7%) 1 (3.2%)
Table 2: Comparison of ulcer characteristics between the two groups.
Control
(n = 12, 50.0%)
Study
(n = 12, 50.0%) P value
Wagner ulcer classiﬁcation .248
Grade 1 2 (16.7%) 1 (8.3%)
Grade 2 10 (83.3%) 11 (91.7%)
Site .791
Forefoot 6 (50.0%) 8 (66.7%)
Midfoot 3 (25.0%) 3 (25.0%)
Hindfoot 3 (25.0%) 1 (8.3%)
Ulcer area (cm2) 19:33 ± 17:39 14:30 ± 9:25 .431
Table 3: Characteristics of common coagulation studies.
Control
(n = 12, 50.0%)
Study
(n = 12, 50.0%) P value
PT (sec: 9.2~12.3∗) 12:36 ± 1:37 13:16 ± 1:83 .283
PT (INR: 0.91~1.16∗) 1:05 ± 0:11 1:12 ± 0:14 .227
aPTT (sec: 26.8~40.6∗) 36:22 ± 22:16 37:15 ± 13:42 .911
∗Reference range.
Table 4: Type of anticoagulants of each group of patients.
Control
(n = 12, 50.0%)
Study
(n = 12, 50.0%)
Aspirin only 3 (25.0) 3 (25.0)
Clopidogrel only 2 (16.7) 3 (25.0)
Aspirin and clopidogrel 6 (50.0) 5 (41.7)
Aspirin and LMWH 1 (8.3) 0 (0)
Warfarin 0 (0) 1 (8.3)
LMWH: low molecular weight heparin.
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tissue and necrotic portion and reduction of bacterial
bioﬁlms and excess matrix metalloproteinases (MMPs)
[14]. However, as we described above, the bleeding tendency
of ulcer increases due to anticoagulation therapy in diabetes
patients.
For overcoming those problems, we suggested that new
developed clotting materials to control massive bleeding at
combat ﬁeld would be applicable to diabetic foot ulcer with
the same goal. The kaolin-impregnated gauze is known as
combat gauze that shows eﬀective hemostasis of the external
bleeding in combat ﬁeld. To avoid diﬃculty in achieving
hemostasis in trauma and interventional procedures,
advanced materials impregnated with kaolin have been
introduced with good results [15, 16]. It used the ﬁrst-line
hemostatic agent for use in treatment of severe hemorrhage
that cannot be controlled by a tourniquet [17].
Kaolin-impregnated dressing is an inert zeolite-based
mineral substance. It is a subsidiary of volcanic rock repro-
duced in the laboratory and acts as a selective sponge been
tested in animal models [18]. When it comes in to contact
with blood, the zeolite rapidly takes the smaller water
molecules from the blood into its numerous pores leaving a
cellular clot behind [19]. This process of physical adsorption
is accompanied by an exothermic reaction which generates
temperatures of up to 105°F [20]. These ﬁndings increased
expectation to those hemostatic materials which might pro-
mote clotting by activation of factor XII (FXII) and factor
XI (FXI) of the intrinsic coagulation pathway by providing
more optimal surrounding. Previous in vivo animal hemor-
rhage models found the kaolin-based gauze to be the most
eﬀective product among four new dressings tested [16]. Tra-
ditionally conventional manual compression dressings using
folded dry gauze are used for the control of bleeding from
diabetic foot ulcer after surgical debridement. However, it is
diﬃcult to manage a continuous oozy bleeding from that
lesion; furthermore, anticoagulant thins the blood. Limited
data exist relative to the eﬀectiveness of hemostatic agents
when the patient suﬀers from diabetic foot ulcer. Currently,
under the author’s knowledge, no study reported hemostatic
eﬀectiveness and safety with diabetic foot ulcer after debride-
ment in an outpatient clinic. Besides, the conventional
manual compression dressing to control a bleeding is well-
known, but the use of hemostatic dressing containing kaolin
can be a new and simple approach to those, either ongoing or
after surgical debridement. In this study, the authors recom-
mend a user-friendly and easy outpatient clinic treatment
protocol for diabetic foot ulcer management with postdebri-
dement bleeding; hemostasis rate is 80% in a 5-minute treat-
ment and 100% within a 10-minute treatment.
The current study has a few limitations. Nevertheless, the
two groups displayed similar demographics (Table 1) and
coagulation ability (Tables 3 and 4); a small number was
recruited due to limited study and budget. However, in this
circumstance, as a strength in the design, a proper sample
size was done before we investigated this study. Second, the
investigator was not blind to the study materials because of
diﬀerent ﬁgure. To avoid the bias, hemostatic endpoint was
checked by an independent observer who was not related to
this study. Additionally, only the presence or absence of
hemostasis was assessed at planned 5 and 10 minutes after
treatment starts. Lastly, a diﬀerent anatomical site of diabetic
foot ulcer is involved to the current study. It might aﬀect the
amount and velocity of bleeding. Despite some limitations,
we believe the prospective, randomized study design might
add objective to the result of this study.
5. Conclusions
The present randomized study demonstrated that a hemo-
static eﬀect based on kaolin-impregnated dressing material
combined with gentle manual compression for a few minutes
is signiﬁcantly superior to a conventional technique with
dry gauze in acquiring the hemostasis after debridement
procedures.
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